Repirinast is a selective histamine release inhibitor and H4 receptor antagonist primarily utilized in the management of bronchial asthma by modulating histamine release from mast cells. This category… Read more
Repirinast is a selective histamine release inhibitor and H4 receptor antagonist primarily utilized in the management of bronchial asthma by modulating histamine release from mast cells. This category provides access to high-quality reference standards, including the active pharmaceutical ingredient, to support rigorous analytical testing and quality control protocols. Chemists and researchers utilize the included impurities for comprehensive impurity profiling, ensuring compliance with regulatory standards throughout the drug development lifecycle. Additionally, stable isotope labelled compounds, such as the deuterated analogue, serve as essential internal standards for precise quantification in complex biological matrices during pharmacokinetic studies and method validation. By incorporating these materials into analytical workflows, laboratories can achieve accurate identification and measurement of the drug and its related substances, facilitating robust development and manufacturing processes for pharmaceutical products.